Long-term survival after fertility-sparing surgery for epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 7, 2009, Pages 1199-1204

  Schlaerth, Alan C ^a   Chi, Dennis S ^a   Poynor, Elizabeth A ^a   Barakat, Richard R ^a   Brown, Carol L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Fertility sparing surgery; Stage I ovarian carcinoma; Surgical staging

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FERTILITY SPARING SURGERY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; ORGAN PRESERVATION; OVARY CANCER; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SALPINGOOOPHORECTOMY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGE; ARTICLE; COMPARATIVE STUDY; EVALUATION; FEMALE INFERTILITY; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL; SURVIVOR;

ADULT; AGE FACTORS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS;

EID: 73449083120     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e31819d82c3     Document Type: Review

References (23)

1. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2003;83(Suppl 1):ix-xxii, 1-229.
2. Monga M, Carmichael JA, Shelley WE, et al. Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. Gynecol Oncol. 1991;43:195-197.
3. Trimbos JB, Parmar M, Vergote I, et al. International Collaborative Ovarian Neoplasm 1; European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy un Ovarian Neoplasm. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst. 2003;95: 105-112.
4. Trimbos JB, Schueler JA, van der Burg M, et al. Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer. Cancer. 1991;67:597-602.
5. Peccatori F, Bonazzi C, Chiari S, et al. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet Gynecol. 1995;86:367-372.
6. Gotlieb WH, Flikker S, Davidson B, et al. Borderline tumors of the ovary. Cancer. 1998;82:141-146.
7. Colombo N, Chiari S, Maggioni A, et al. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol. 1994;55(3 Pt 2): S47-S51.
8. Zanetta G, Chiari S, Rota S, et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol. 1997;104:1030-1035.
9. Gonzalez-Lira G, Escudero-De Los Rios P, Salazar-Martinez E, et al. Conservative surgery for ovarian cancer and effect on fertility. Int J Gynaecol Obstet. 1997;56:155-162. (Pubitemid 27084808)
10. Raspagliesi F, Fontanelli R, Paladini D, et al. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg. 1997;185: 457-460.
11. Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002; 87:1-7.
12. Morice P, Leblanc E, Rey A, et al. GCCLCC and SFOG. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique). Hum Reprod. 2005;20:1379-1385.
13. Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072-3076.
14. Tsumura N, Sakuragi N, Hareyama H, et al. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer. 1998;79:526-530.
15. Burghardt E, Girardi F, Lahousen M, et al. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol. 1991;40:103-106.
16. Cass I, Li AJ, Runowicz CD, et al. Patterns of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol. 2001;80:56-61.
17. Munnell EW. Is conservative therapy ever justified in stage I(IA) cancer of the ovary? Am J Obstet Gynecol. 1969;103:641-653.
18. Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol. 1999;72: 288-291.
19. Zaino R, Whitney C, Brady MF, et al. Simultaneously detected endometrial and ovarian carcinomas-a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group study. Gynecol Oncol. 2001;83:355-362.
20. Moore MM, Tewari K, Rose GS, et al. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient. Gynecol Oncol. 1999;73:452-454.
21. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial carcinoma. Lancet. 2001;357:176-182.
22. Eitan R, Chi DS. Successful pregnancies following fertility-preserving treatment for ovarian carcinoma. Nat Clin Pract Oncol. 2005;2: 647-651.
23. Colombo N, Parma G, Lapresa MT, et al. Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer. 2005;15:206-211.